Triazine compounds as antagonists at Bv8-prokineticin receptors

Journal of Medicinal Chemistry

Volumn 51, Issue 23, 2008, Pages 7635-7639

  Balboni, Gianfranco ^a,d   Lazzari, Ilaria ^a   Trapella, Claudio ^a   Negri, Lucia ^b   Lattanzi, Roberta ^b   Giannini, Elisa ^b   Nicotra, Annalisa ^b   Melchiorri, Pietro ^b   Visentin, Sergio ^c   De Nuccio, Chiara ^c   Salvadori, Severo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 (2 AMINOETHYLAMINO) 3 (4 ETHYLBENZYL) 1 (4 METHOXYBENZYL) 1,3,5 TRIAZINE 2,4(1H,3H) DIONE; 6 [2 (4,5 DIHYDRO 1H IMIDAZOL 2 YLAMINO)ETHYLAMINO] 3 (4 ETHYLBENZYL) 1 (4 METHOXYBENZYL) 1,3,5 TRIAZINE 2,4(1H,3H) DIONE; [2 [5 (4 ETHYLBENZYL) 1 (4 METHOXYBENZYL) 1,4,5,6 TETRAHYDRO 4,6 DIOXO 1,3,5 TRIAZIN 2 YLAMINO]ETHYL]GUANIDINE; CALCIUM ION; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROKINETICIN RECEPTOR 1; PROKINETICIN RECEPTOR 2; PROKINETICIN RECEPTOR BLOCKING AGENT; RECEPTOR BLOCKING AGENT; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION;

BINDING SITES; CALCIUM; CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; GASTROINTESTINAL HORMONES; HUMANS; LIGANDS; MOLECULAR STRUCTURE; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZINES;

EID: 57349149440     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800854e     Document Type: Article

References (18)

1. Mollay, C.; Wechselberger, C.; Mignogna, G.; Negri, L.; Melchiorri, P.; Barra, D.; Kreil, G. Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur. J. Pharmacol. 1999, 374, 189-196.
2. Kaser, A.; Winklmayr, M.; Lepperdinger, G.; Kreil, G. The AVIT protein family. Secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep. 2003, 4, 469-473.
3. Li, M.; Bullock, C. M.; Knauer, D. J.; Ehlert, F. J.; Zhou, Q. Y. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol. Pharmacol. 2001, 59, 692-698.
4. Lin, D. C.; Bullock, C. M.; Ehlert, F. J.; Chen, J. L.; Tian, H.; Zhou, Q. Y. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J. Biol. Chem. 2002, 277, 19276-19280.
5. Masuda, Y.; Takatsu, Y.; Terao, Y.; Kumano, S.; Ishibashi, Y.; Suenaga, M.; Abe, M.; Fukusumi, S.; Watanabe, T.; Shintani, Y.; Yamada, T.; Hinuma, S.; Inatomi, N.; Ohtaki, T.; Onda, H.; Fujino, M. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem. Biophys. Res. Commun. 2002, 293, 396-402.
6. Soga, T.; Matsumoto, S.; Oda, T.; Saito, T.; Hiyama, H.; Takasaki, J.; Kamohara, M.; Ohishi, T.; Matsushime, H.; Furuichi, K. Molecular cloning and characterization of prokineticin receptors. Biochim. Biophys. Acta 2002, 1579, 173-179.
7. LeCouter, J.; Kowalski, J.; Foster, J.; Hass, P.; Zhang, Z.; Dillard-Telm, L.; Frantz, G.; Rangell, L.; Deguzman, L.; Keller, G.; Peale, F.; Gurney, A.; Hillan, Kj.; Ferrara, N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001, 412, 876-884.
8. Shojaei, F.; Wu, X.; Zhong, C.; Yu, L.; Liang, X. H.; Yao, J.; Blanchard, D.; Bais, C.; Peale, F. V.; Van Bruggen, N.; Ho, C.; Ross, J.; Tan, M.; Carano, R. A.; Meng, Y. G.; Ferrara, N. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007, 450, 825-831.
9. Zhou, Q. Y. The prokineticins: a novel pair of regulatory peptides. Mol. Interv. 2006, 6, 3330-3338.
10. Negri, L.; Lattanzi, R.; Giannini, E.; Melchiorri, P. Bv8/Prokineticin proteins and their receptors. Life Sci. 2007, 81, 1103-1116.
11. Negri, L.; Lattanzi, R.; Giannini, E.; Melchiorri, P. Modulators of pain: Bv8 and prokineticins. Curr. Neuropharmacol. 2006, 4, 207-215.
12. Negri, L.; Lattanzi, R.; Giannini, E.; Colucci, M.; Margheriti, F.; Melchiorri, P.; Vellani, V.; Tian, H.; De Felice, M.; Porreca, F. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behaviour. J. Neurosci. 2006, 26, 6716-6727.
13. Bullock, C. M.; Li, J. D.; Zhou, Q. Y. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol. Pharmacol. 2004, 65, 582-588.
14. Negri, L.; Lattanzi, R.; Giannini, E.; Colucci, M. A.; Mignogna, G.; Barra, D.; Grohovaz, F.; Codazzi, F.; Kaiser, A.; Kreil, G.; Melchiorri, P. Biological activities of Bv8 analogues. Br. J. Pharmacol. 2005, 146, 625-632.
15. Coats, S. J.; Dyatkin, A. B.; He, W.; Lisko, J.; Ralbovsky, J. L.; Schultz, M. J. Prokineticin 1 receptor antagonists. Patent WO2006104715, 2006.
16. Coats, S. J.; Dyatkin, A. B.; He, W.; Lisko, J.; Ralbovsky, J. L.; Schultz, M. J. Pyrimidindione derivatives as prokineticin 2 receptor antagonists. Patent WO2006104713, 2006.
17. Coats, S. J.; Dyatkin, A. B.; He, W.; Lisko, J.; Miskowski, T. A.; Ralbovsky, J. L.; Schultz, M. J. Prokineticin 2 receptor antagonists. Patent WO2007079214, 2007.
18. Thompson, W. J.; Melamed, J. Y. Preparation of morpholinecarboxamides as prokineticin 2 receptor antagonists. Patent WO2007067511, 2007.